-
摘要: 经过20多年的发展, 小肠移植已成为肠功能衰竭患者的临床标准治疗方式。全球小肠移植登记中心(ITR)显示, 截止至2013年2月, 全球82个移植中心共对2 699例患者完成了2 887次小肠移植。小肠移植的近期疗效取得了巨大进步, 但远期疗效仍不令人满意。肠功能衰竭的残存小肠康复治疗和延长成形术的进步及营养支持技术的改进, 客观上减少了小肠移植适应证患者数量, 小肠移植存在困惑和挑战。随着近年来对小肠移植体液性排斥反应监测和治疗的重视, 小肠移植的远期预后有望得到改善。
-
[1] 李元新, 李宁.小肠移植:一个时代的到来[J].器官移植, 2010, 1(2):69-72. http://www.organtranspl.com/browse/detail/qkid/29/id/416.htmlLi YX, Li N. Intestinal transplantation: the arrival of an era[J]. Organ Transplant, 2010, 1(2):69-72. http://www.organtranspl.com/browse/detail/qkid/29/id/416.html [2] 李元新.小肠移植的关键外科技术[J].器官移植, 2012, 3(3):121-126. http://www.organtranspl.com/browse/detail/qkid/29/id/592.htmlLi YX. Pivotal surgical techniques for small bowel transplantation[J]. Organ Transplant, 2012, 3(3):121-126 http://www.organtranspl.com/browse/detail/qkid/29/id/592.html [3] Abu-Elmagd KM, Costa G, Bond GJ, et al. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges[J]. Ann Surg, 2009, 250(4):567-581. [4] Smith JM, Skeans MA, Horslen SP, et al. OPTN/SRTR 2013 Annual Data Report: intestine[J]. Am J Transplant, 2015, 15(Suppl 2):1-16. [5] Grant D, Abu-Elmagd K, Mazariegos G, et al. Intestinal transplant registry report: global activity and trends[J]. Am J Transplant, 2015, 15(1):210-219. doi: 10.1111/ajt.12979 [6] 李元新, 周欣, 李宁, 等.生长激素联合谷氨酰胺对促进残存小肠适应性代偿的研究[J].肠外与肠内营养, 2004, 11(1):8-13. http://www.cnki.com.cn/Article/CJFDTOTAL-CWCN200401002.htmLi YX, Zhou X, Li N, et al. Growth hormone with glutamine accelerate remnant intestinal adaptation after massive small bowel resection in rat[J]. Parenter Enteral Nutr, 2004, 11(1):8-13. http://www.cnki.com.cn/Article/CJFDTOTAL-CWCN200401002.htm [7] 郭明晓, 李幼生, 李元新, 等.肠康复治疗对短肠综合征病人残余小肠黏膜形态学的影响[J].肠外与肠内营养, 2011, 18(6):326-330. http://www.cnki.com.cn/Article/CJFDTOTAL-CWCN201106004.htmGuo MX, Li YS, Li YX, et al. The effect of growth hormone, glutamine and optimal diet fiber enteral nutrition on intestinal mucosal morphology in patients with short bowel syndrome[J]. Parenter Enteral Nutr, 2011, 18(6):326-330. http://www.cnki.com.cn/Article/CJFDTOTAL-CWCN201106004.htm [8] Burness CB, McCormack PL. Teduglutide: a review of its use in the treatment of patients with short bowel syndrome[J]. Drugs, 2013, 73(9):935-947. doi: 10.1007/s40265-013-0070-y [9] Jeppesen PB, Pertkiewicz M, Messing B, et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure[J].Gastroenterology, 2012, 143(6):1473-1481. doi: 10.1053/j.gastro.2012.09.007 [10] Tannuri U.Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure, and serialtransverse enteroplasty for short bowel syndrome[J]. J Pediatr Surg, 2003, 38(12):1845-1846. [11] Kim HB, Lee PW, Garza J, et al. Serial transverse enteroplasty for short bowel syndrome: a case report[J]. J Pediatr Surg, 2003, 38(6):881-885. doi: 10.1016/S0022-3468(03)00115-5 [12] Frongia G, Kessler M, Weih S, et al. Comparison of LILT and STEP procedures in children with short bowel syndrome: a systematic review of the literature[J]. J Pediatr Surg, 2013, 48(8):1794-1805. doi: 10.1016/j.jpedsurg.2013.05.018 [13] Pironi L, Joly F, Forbes A, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation[J]. Gut, 2011, 60(1):17-25. doi: 10.1136/gut.2010.223255 [14] Squires RH, Duggan C, Teitelbaum DH, et al. Natural history of pediatric intestinal failure: initial report from the Pediatric Intestinal Failure Consortium[J]. J Pediatr, 2012, 161(4):723-728. doi: 10.1016/j.jpeds.2012.03.062 [15] Sudan D. The current state of intestine transplantation: indications, techniques, outcomes and challenges[J]. Am J Transplant, 2014, 14(9):1976-1984. doi: 10.1111/ajt.12812 [16] 李元新, 石炳毅, 刘磊, 等.1例小肠移植术后抗体介导的血管性排斥反应诊断与治疗[J].军医进修学院学报, 2012, 33(1):12-15. http://www.cnki.com.cn/Article/CJFDTOTAL-JYJX201201005.htmLi YX, Shi BY, Liu L, et al. Antibodv-mediated vascular reiection after intestine transplantation: a case report[J]. J Chin PLA Postgrad Med Sch, 2012, 33(1):12-15. http://www.cnki.com.cn/Article/CJFDTOTAL-JYJX201201005.htm [17] Tsai HL, Island ER, Chang JW, et al. Association between donor-specific antibodies and acute rejection and resolution in small bowel and multivisceral transplantation[J]. Transplantation, 2011, 92(6):709-715. doi: 10.1097/TP.0b013e318229f752 [18] Berger M, Zeevi A, Farmer DG, et al. Immunologic challenges in small bowel transplantation[J]. Am J Transplant, 2012, 12(Suppl 4):S2-S8. [19] 李元新.小肠移植免疫抑制方案的发展历史、现状和展望[J/CD].中华移植杂志(电子版), 2011, 5(4):271-276.Li YX. History, current status, and perspective of immunosuppressive protocols in small bowel transplantation[J/CD]. Chin J Transplant(Electr Edit):2011, 5(4):271-276. [20] Stegall MD, Diwan T, Raghavaiah S, et al. Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients[J]. Am J Transplant, 2011, 11(11):2405-2413. doi: 10.1111/ajt.2011.11.issue-11 [21] Abu-Elmagd KM, Kosmach-Park B, Costa G, et al. Long-term survival, nutritional autonomy, and quality of life after intestinal and multivisceral transplantation[J]. Ann Surg, 2012, 256(3):494-508. doi: 10.1097/SLA.0b013e318265f310 [22] Sudan D. Cost and quality of life after intestinal transplantation[J]. Gastroenterology, 2006, 130(2 Suppl 1):S158-S162.
点击查看大图
计量
- 文章访问数: 101
- HTML全文浏览量: 80
- PDF下载量: 17
- 被引次数: 0